甲状腺微小乳头状癌的诊治与思考

Diagnosis and treatment of papillary thyroid microcarcinoma

甲状腺疾病在临床上常见,且近年来发病率有逐年升高的趋势,其中甲状腺癌占有较高的比例。随着诊疗水平的不断提高,甲状腺微小乳头状癌(papillary thyroid microcarcinoma,PTMC)的检出率也逐年升高,但是临床上关于甲状腺微小乳头状癌的诊疗问题存在争议,在传统的诊疗中,绝大多数医生倾向于将PTMC归属于恶性肿瘤行列,而在现代临床研究,部分学者更倾向于将PTMC划分至“甲状腺良性肿瘤”,以至于在PTMC的诊治中存在了一定的分歧,为了达到个体化治疗、规范化治疗和精准化治疗的目的,临床上部分专家学者提出了更多新的看法和见解。现就目前国内外对于PTMC的诊治方面进行简要阐述。

Thyroid diseases,common health problems in clinical practice,have shown an increasing incidence year by year in recent years,among which thyroid cancer accounts for a high proportion.As diagnostic techniques are progressing,papillary thyroid microcarcinoma(PTMC)has been detected more and more frequently,but its diagnosis and treatment becomes debated.In traditional views,the vast majority of doctors tended to classify PTMC as a malignant tumor;however,modern clinical research makes some scholars turn to the opposite opinion-a benign tumor,generating a certain divergence in the diagnosis and treatment of PTMC.Some clinical experts and scholars have put forward new insights into individualized,standardized,and targeted treatment.This paper briefly discusses the diagnosis and treatment of PTMC at home and abroad.